Pillsbury Winthrop Shaw Pittman LLP advised Alume Biosciences on the deal.Alume Biosciences, a leader in the field of nerve-targeted diagnostics and therapeutics, announced a $13 million Series…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
